#WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen …

Sectors: Biotechnology

Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex …

Sectors: Biotechnology Pharmaceutical

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing …

Sectors: Health

[Automatic translation follows] Official LinkedIn page of France Travail #AvecFranceTravail France Travail is a major player in the French employment market, where it is committed to facilitating the return to work of job seekers and offering companies solutions adapted to their recruitment needs. France Travail's 55,000 employees work every day to be the link between job seekers and companies. France Travail is a key player in the French employment market. Its role is to help the unemployed find work and support companies to fulfil their recruitment requirements. Day-to-day, France Travail's 55,000 staff provides that vital link between job seekers and …

Sectors: Human ressources

New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, …

Tags: DAX30 Sectors: Biotechnology Pharmaceutical

We are EssilorLuxottica, a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018 by the combination of Essilor and Luxottica, our Company combines two centuries of innovation and human endeavour to elevate vision care and the consumer experience around it. We are home to the most loved and widely-recognized vision care and eyewear brands in the world. Our proprietary eyewear brands include Ray-Ban, Oakley, Costa, Vogue Eyewear, Persol and Oliver Peoples, complemented by over 20 prestigious licensed brands. Our advanced lens technologies include Varilux, Crizal, Eyezen, Stellest and Transitions. We offer superior …

Tags: CAC40 Sectors: Optical systems

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Veolia is the benchmark company for ecological transformation. Veolia group aims to be the benchmark company for ecological transformation. With nearly 220,000 employees worldwide, the Group designs and provides game-changing solutions that are both useful and practical for water, waste and energy management. Through its three complementary business activities, Veolia helps to develop access to resources, preserve available resources, and replenish them. In 2021, the Veolia group supplied 79 million people with drinking water and 61 million people with wastewater service, produced nearly 48 million megawatt hours of energy and treated 48 million metric tons of waste. Veolia Environnement (listed …

Tags: CAC40 Sectors: Energy

[Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor that allows, on behalf of the State, access to health products in France and ensures their safety throughout their life cycle. At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after it is placed on the market. Through our assessments, our expertise and our monitoring …

[Automatic translation follows] Official page of the High Authority for Health (HAS), an independent public authority with a scientific character The HAS is an independent public authority whose aim is to contribute to the regulation of the health system through quality. Its missions in the fields of the evaluation of health products, professional practices, the organization of care and public health, aim to ensure that all patients and users have sustainable and equitable access to care that is as effective, safe and efficient as possible.

Karista is a VC firm investing in game changers from scratch to success. Karista is an early-stage venture capital firm investing in ambitious entrepreneurs. For the past 20 years, we have been backing and guiding more than 100 companies from inception to success in Health, Digital, and Technology. Because we believe that investment is not only about money but mainly about people, we provide support to our founders and entrepreneurs very early-on. We come from different backgrounds and bring various skills to help nurturing our portfolio companies on many levels. We are currently deploying three European early stage funds: our …

Sectors: Startup accelerator & VC

[Automatic translation follows] Acting together for responsible growth. MEDEF is the leading network of entrepreneurs in France. It defends and promotes companies of all sizes and in all sectors of activity. A privileged interlocutor for decision-makers and public authorities In complete transparency, MEDEF conducts ongoing lobbying with all decision-makers at local, regional, national and European levels, in order to assert the company's point of view and to lighten its tax and regulatory burden: reform of the professional tax, apprenticeship, business transfer, conventional termination, etc. A key partner in social dialogue Authorized by law to negotiate on behalf of all companies …

Sectors: NGO, Think Tank

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its …

Sectors: Startup accelerator & VC

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.

Sectors: Biotechnology French Cluster Public business cluster

The service catalyst for the community of healthcare innovators in the south of France. Created in 2005, the Eurobiomed competitiveness cluster helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d'Azur and Occitanie/Pyrénées-Méditerranée regions at the cutting edge of innovation. Its aim is to foster the growth and projects of innovative healthcare companies in the region. From immunology and dermatology to neurology, oncology and digital health, Eurobiomed supports French and European public economic development strategies, helping to position its members as European champions and anchor France among the world leaders in healthcare innovation. Eurobiomed brings together all healthcare players, …

Sectors: Biotechnology French Cluster Public business cluster

Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment …

Sectors: Biotechnology French Cluster Public business cluster

Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par …

Sectors: Health

Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy

Sectors: Biotechnology

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical

[Automatic translation follows] You act better when you are sure At Ipsos, we are passionately curious about people, markets, brands and society. We help our clients navigate a changing world faster and more easily. We provide them with the inspiration they need to make strategic decisions. We deliver security, speed, simplicity and substance. We are GAME CHANGERS. Marketing Studies, Market Research, Advertising, Media, content and new technologies, Opinion, Customer relations and satisfaction, CRM, Manager and employee engagement, Omnibus, Access Panels, Major Surveys, Qualitative Studies, and Product and service innovation

Sectors: Polling institute

Technological & psychosocial research to improve the health and social inclusion of senior citizens The Broca Living Lab, located within the Broca Hospital (AP-HP) in Paris (France), has been studying and contributing to the development and evaluation of new technologies that promote health, autonomy and social inclusion of older persons for more than 10 years. santé, living lab, innovation, maladie d'Alzheimer, études cliniques, robotique, qualité de vie, éthique, ergonomie cognitive, stimulation cognitive, dispositifs technologiques, autonomie, aidants, and gérontechnologies

The biggest startup campus in the world. STATION F is the world's biggest startup campus based in Paris, gathering a whole entrepreneurial ecosystem under one roof. Startups

Sectors: Startup accelerator & VC

[Automatic translation follows] Working at Health Insurance means giving a new dimension to your job and acting every day to protect our health system. Participate in a wide variety of projects in a caring environment and be proud to contribute to an essential mission: acting together, protecting everyone. For nearly 80 years, Health Insurance has played a major role in serving national solidarity. We are convinced that the key to the sustainability of the health system is a collective responsibility and lies in the strong involvement of each of its stakeholders. Within this system, Health Insurance has a triple mission: …

Sectors: Insurance

[Automatic translation follows] Official account of the Ministry of Health and Access to Care. The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse …

Sectors: Pharmaceutical

[Automatic translation follows] INRAE, French National Research Institute for Agriculture, Food and the Environment INRAE, the French National Research Institute for Agriculture, Food and the Environment, is a major player in research and innovation created on January 1, 2020. A finalized research institute resulting from the merger between Inra and Irstea, INRAE ​​brings together a community of 12,000 people, with just over 200 research units and around forty experimental units located in 18 centers throughout France. The institute is positioned among the very first world leaders in agricultural and food sciences, plant and animal sciences, and ranks 11th worldwide in …

Sectors: Research

[Automatic translation follows] GRDF, the main gas distributor in France GRDF is the main operator of the natural gas distribution network in France. Our job is to design, build, operate, maintain and develop this network. These infrastructures measure nearly 200,000 km and are the longest natural gas network in Europe: 5 times around the Earth. This network, a key element of the energy transition, also meets the need to develop biomethane, Natural Gas Vehicles and Power-to-Gas. Our 12,000 employees work in 9,500 municipalities to allow 11 million homes and businesses in France to benefit from access to our network. They …

Sectors: Energy

[Automatic translation follows] Prevention / Care / Research / Education, at the service of patients with #cancer. Gustave Roussy, the leading cancer center in Europe, the 4th best cancer hospital in the world, is a global center of expertise against cancer, at the service of patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Greater Paris). A private institution of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and education

Sectors: Health

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, …

Sectors: Pharmaceutical

Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 1,930 listed issuers and around €6.8 trillion in market capitalisation as of end March 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total …

Sectors: Finance

[Automatic translation follows] PariSanté Campus, here digital health grows! PariSanté Campus aims to create a coherent and synergistic group of public and private operators, with the ambition of structuring a research and innovation sector in digital health with global influence. This group will be set up on the site of the former Val-de-Grâce military training hospital, and to create a network of partnerships in the Paris region, nationally and internationally. The group will be financed by unprecedented investments from the recovery plan, and will aim to be a major vector for the creation of medical-scientific, but also economic, value. Based …

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we …

Sectors: Biotechnology

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical

EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, …

Sectors: Consulting, audit

The official #EUGreenCapital and #EUGreenLeaf Awards. Our aim is to improve Europe's urban environment. The European Green Capital and European Green Leaf awards are a European Commission initiative to recognise a city's commitment to a better urban environment. Cities with populations over 100,000 inhabitants are eligible to apply for the European Green Capital Award while the European Green Leaf is open to cities of between 20,000 and 100,000 inhabitants. Winners demonstrate well-established records of high environmental standards and a commitment to setting ambitious goals for future environmental progress, underpinned by the practical application of sustainable development. The schemes have a …

Sectors: European Union

Philosophy The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve."​ This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, …

Sectors: Pharmaceutical

Incubateur des start-up tech et deeptech du cluster Paris-Saclay Accompagnement de projets de création d'entreprises technologiques innovants Entrepreneurship, Consulting, Technology, Public R&D, Innovation, and Investment

Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our …

Sectors: Pharmaceutical

Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.

Sectors: Pharmaceutical

[Automatic translation follows] Success is within you. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FRB - De la recherche à la société The Foundation for Research on Biodiversity is a platform for the different scientific players and stakeholders in society concerned with biodiversity. It was created in 2008, following the Grenelle Environment Forum, with the support of the ministries for research and ecology and eight public research establishments, joined by LVMH in 2014. Generating innovation, promoting scientific projects in association with society and developing studies, overviews and valuations are at the core of the foundation’s missions. Up until now, more than 170 structures, associations, businesses, managers or authorities have joined the FRB with the …

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, …

Sectors: Pharmaceutical

[Automatic translation follows] Serving health The Diaconesses Croix Saint-Simon Hospital Group is now the largest private hospital center of collective interest in eastern Paris. The establishment offers a wide range of care: internal medicine, orthopedic, digestive, gynecological and urological surgeries, proctology, oncology, rheumatology, acute geriatrics, emergencies, maternity and palliative care. It is also one of the most efficient fertility centers to date. Historically a pioneer in many fields and always looking to the future, the hospital group participates in multiple clinical research projects in most of its specialties. It also forges strong links with other health and medico-social structures in …

Sectors: Health

[Automatic translation follows] Incubates Deep Tech startups & accelerates scientific innovations from the R&D labs of Lyon-St Etienne 🚀 PULSALYS, the Deep Tech innovation incubator and accelerator of Lyon & St Etienne, builds the innovative products & services of tomorrow, by transforming scientific discoveries from the laboratories of the University of Lyon into economic opportunities for companies and startups. Created in December 2013 as part of the Future Investment Program (PIA) under the status of Technology Transfer Acceleration Company (SATT), PULSALYS has become a key player in the attractiveness and economic development of the Lyon - St-Etienne region. Chemistry & …

Tags: SATT Network Sectors: Research

[Automatic translation follows] The Agency for Ecological Transition! ADEME in brief The Agency for Ecological Transition participates in the implementation of public policies in the areas of the environment, energy and sustainable development. It provides its expertise and consulting capabilities to businesses, local authorities, public authorities and the general public, in order to enable them to progress in their environmental approach. The Agency also helps to finance projects, from research to implementation, in the following areas: waste management, soil preservation, energy efficiency and renewable energies, savings on raw materials, air quality, noise control, the transition to the circular economy and …

Sectors: National and local authorities

Transforming an invention into an innovation is a wonderful experience. And we’re fortunate, it is our job. From dream to reality, from lab to market | a researcher and his/her team make an extraordinary discovery. But how can an idea be transformed into a solution, and how can an invention be turned into an innovation? This is the start of a race against time to find the partner company capable of upholding that ambition. Fortunately, SATT Sud-Est is there to help in this undertaking and make this great story come true. Transforming an invention into an innovation is a wonderful …

Tags: SATT Network Sectors: National and local authorities Research

[Automatic translation follows] Search, find, heal, for you and with you. Created in 2010, the Brain Institute is a scientific and medical research center of excellence dedicated to the study of the brain and the discovery of new treatments for diseases of the nervous system. Its innovative model brings together patients, doctors, researchers and entrepreneurs with a common goal: to transform fundamental discoveries into therapeutic solutions via a translational and interdisciplinary approach. Located in Paris at the heart of the Pitié-Salpêtrière Hospital – the largest neurology center in Europe – the Brain Institute brings together more than 900 international experts …

Sectors: Startup accelerator & VC

[Automatic translation follows] 1st foundation for research against pain in France A major public health problem, chronic pain now affects 1 in 5 adults, or more than 12 million French people. And since the therapeutic arsenal is both aging and insufficient, nearly two thirds of patients believe that their pain is insufficiently controlled. Pain also has a very significant impact on health at work. Back pain is the leading cause of disability in the world and musculoskeletal disorders are the leading cause of occupational illness in France. Pain alone impacts 88 million working days per year in France. Fighting pain …

Sectors: Research

The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players !

[Automatic translation follows] The ministry is organized into four technical departments (food, education and research, economic and environmental performance of companies, fisheries and aquaculture) whose action is coordinated by a general secretariat that ensures human resources management, financial affairs, service organization, information and communication, agricultural statistics and forecasting, legal affairs and pilots the ministry's modernization policy The decentralized services relay the action of the central administration in the regions and departments. The ministry has nearly 36,000 employees, half of whom work in the agricultural education and training sector. Food, Agriculture, Forestry, Agri-food, and Fisheries

Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free …

Sectors: Finance

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments …

Sectors: Pharmaceutical

Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Sectors: Biotechnology Pharmaceutical

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines

Sectors: Pharmaceutical

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

[Automatic translation follows] Welcome to a world of content The TF1 group is a global player in the production, editing and distribution of content. Through its content, its ambition is to inspire society positively. The TF1 group organizes its activities in several additional poles: • The Broadcast pole with 5 clear channels (TF1, TMC, TFX, TF1 Films series, LCI), 4 thematic channels (Ushuaia TV, TV history, Breizh TV, Club series), 2 content platforms on demand (MyTF1, Tfou max), and the TF1 advertising. • The production center with Newen, which brings together 9 studios in France and internationally. • The digital …

Sectors: Media

Every company has a mission. What's ours? To empower every person and every organization to achieve more. We believe technology can and should be a force for good and that meaningful innovation contributes to a brighter world in the future and today. Our culture doesn’t just encourage curiosity; it embraces it. Each day we make progress together by showing up as our authentic selves. We show up with a learn-it-all mentality. We show up cheering on others, knowing their success doesn't diminish our own. We show up every day open to learning our own biases, changing our behavior, and inviting …

Sectors: IT services

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical